In total, 731 collections of psychoactive products were carried out under the OFDT's SINTES system in 2023, an increase of 17% compared to 2022.
10 thematic workbooks describing the national situation on drugs in France in 2023.
In France, half of 17-year-olds have tried cigarettes, and nearly a third have tried cannabis. How do parents deal with this reality? The ARAMIS 2 survey questions parents of young consumers about parental control over their use.
This briefing paper aims to identify trends, and emerging and/or less widespread phenomena in the use of illicit drugs in Martinique in order to contribute to the understanding and knowledge of their developments in the longer term.
The 2022-2023 National Adolescent Health and Substance Use Survey in Middle and High Schools (EnCLASS) interviewed a representative sample of pupils enrolled in high schools about their health, lifestyle habits, and possible use of psychoactive substances.
Results of the ESSPRI survey evidence a significant exposure to psychoactive substances among adult male inmates in mainland France, regardless of sentences lengths, irrespective of prison type and criminal status (awaiting trial or convicted).
This year, 132 specialised drug treatment centres (CSAPA) participated in the RECAP survey (common data collection on addictions and treatments), out of a total of around 500 CSAPAs, providing data on more than 210 000 patients.
For the past two decades the Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD) conducted by the OFDT has made it possible to quantify the use of psychoactive substance by 17-year-olds at a regional level.
An overview of the criminal justice responses to offences related to driving under the influence of alcohol or drugs since the 1990s.
Psychoactive substance use among middle school and high school students: results of the EnCLASS 2022 survey.
A total of 623 psychoactive products were collected under the SINTES scheme in 2022, an increase of 18% compared with the previous year.
2022 main observations of the OFDT's TREND scheme, which has been monitoring emerging phenomena and developments in the field of drugs (markets, users) since 1999:
In March 2022, the ESCAPAD survey interviewed a representative sample of 23 701 French girls and boys with an average age of 17.4 years.
This report of the RECAP survey (common data collection on addictions and treatments) reviews the main recent changes in the statistics on people with addictive behaviour problems accompanied and cared for by teams from specialised drug treatment centres (CSAPA in French).
Assessment of developments in use and access to care, marked by the health crisis linked to Covid-19.
In 2021, the Health Barometer survey conducted by Santé publique France questioned 23 661 adults about their cannabis use.
In 2021, the quantities seized by the police, the gendarmerie and customs have reached unprecedented levels for marijuana, cocaine and even heroin. In addition, the levels of substances circulating the country from cannabis resin and heroin to cocaine and MDMA/ecstasy are high, while retail prices are fairly stable or down slightly.
This note first reviews the process of administrative recognition of the status of unaccompanied minors and the socio-demographic characterisation of this population.
A total of 32 new synthetic products were identified in France in 2021, with the emergence of synthetic opioids and the progression of synthetic cannabinoids. Among these 32 new identifications, 12 were made from samples collected for SINTES, the French National Detection System of Drugs and Toxic Substances.
This document, produced in collaboration with the Regional Health Observatories of Martinique, French Guiana and Réunion, presents the results of the EnCLASS 2021 survey in these three territories.